China Isotope & Radiation Past Earnings Performance
Past criteria checks 1/6
China Isotope & Radiation has been growing earnings at an average annual rate of 5.7%, while the Medical Equipment industry saw earnings growing at 10.9% annually. Revenues have been growing at an average rate of 14.6% per year. China Isotope & Radiation's return on equity is 10.9%, and it has net margins of 5.6%.
Key information
5.7%
Earnings growth rate
4.5%
EPS growth rate
| Medical Equipment Industry Growth | 13.7% |
| Revenue growth rate | 14.6% |
| Return on equity | 10.9% |
| Net Margin | 5.6% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Why We're Not Concerned About China Isotope & Radiation Corporation's (HKG:1763) Share Price
Apr 26
China Isotope & Radiation (HKG:1763) Has A Rock Solid Balance Sheet
Mar 28There Are Reasons To Feel Uneasy About China Isotope & Radiation's (HKG:1763) Returns On Capital
May 13Is Now The Time To Look At Buying China Isotope & Radiation Corporation (HKG:1763)?
Feb 07China Isotope & Radiation (HKG:1763) Will Want To Turn Around Its Return Trends
Dec 20A Look At The Intrinsic Value Of China Isotope & Radiation Corporation (HKG:1763)
Oct 28China Isotope & Radiation (HKG:1763) Seems To Use Debt Quite Sensibly
Sep 30There Are Reasons To Feel Uneasy About China Isotope & Radiation's (HKG:1763) Returns On Capital
Aug 30Is There Now An Opportunity In China Isotope & Radiation Corporation (HKG:1763)?
Jun 10China Isotope & Radiation (HKG:1763) Could Easily Take On More Debt
Apr 11Is It Time To Consider Buying China Isotope & Radiation Corporation (HKG:1763)?
Dec 28China Isotope & Radiation (HKG:1763) Seems To Use Debt Quite Sensibly
Oct 26Capital Allocation Trends At China Isotope & Radiation (HKG:1763) Aren't Ideal
Oct 08Is Now An Opportune Moment To Examine China Isotope & Radiation Corporation (HKG:1763)?
Sep 05Returns On Capital At China Isotope & Radiation (HKG:1763) Paint A Concerning Picture
Jun 13When Should You Buy China Isotope & Radiation Corporation (HKG:1763)?
May 24China Isotope & Radiation (HKG:1763) Has A Pretty Healthy Balance Sheet
Apr 01Our Take On The Returns On Capital At China Isotope & Radiation (HKG:1763)
Mar 14The China Isotope & Radiation (HKG:1763) Share Price Has Gained 24% And Shareholders Are Hoping For More
Feb 04
Is Now The Time To Look At Buying China Isotope & Radiation Corporation (HKG:1763)?
Jan 09Will China Isotope & Radiation (HKG:1763) Multiply In Value Going Forward?
Dec 14China Isotope & Radiation Corporation's (HKG:1763) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Nov 23Revenue & Expenses BreakdownBeta
How China Isotope & Radiation makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 6,635 | 371 | 2,477 | 306 |
| 30 Sep 23 | 6,451 | 388 | 2,391 | 313 |
| 30 Jun 23 | 6,267 | 407 | 2,305 | 319 |
| 31 Mar 23 | 6,207 | 399 | 2,350 | 310 |
| 31 Dec 22 | 6,146 | 392 | 2,394 | 301 |
| 30 Sep 22 | 5,926 | 367 | 2,429 | 267 |
| 30 Jun 22 | 5,705 | 341 | 2,463 | 233 |
| 31 Mar 22 | 5,425 | 338 | 2,397 | 214 |
| 31 Dec 21 | 5,144 | 336 | 2,331 | 196 |
| 30 Sep 21 | 4,979 | 292 | 2,289 | 192 |
| 30 Jun 21 | 4,815 | 248 | 2,247 | 188 |
| 31 Mar 21 | 4,544 | 231 | 2,083 | 170 |
| 31 Dec 20 | 4,274 | 214 | 1,918 | 153 |
| 30 Sep 20 | 4,063 | 233 | 1,943 | 99 |
| 30 Jun 20 | 3,851 | 253 | 1,967 | 45 |
| 31 Mar 20 | 3,920 | 291 | 2,073 | 22 |
| 31 Dec 19 | 3,989 | 329 | 2,179 | 0 |
| 30 Sep 19 | 3,760 | 341 | 2,036 | 0 |
| 30 Jun 19 | 3,531 | 352 | 1,894 | 0 |
| 31 Mar 19 | 3,390 | 337 | 1,804 | 0 |
| 31 Dec 18 | 3,250 | 322 | 1,715 | 0 |
| 30 Sep 18 | 3,085 | 308 | 1,617 | 0 |
| 30 Jun 18 | 2,920 | 294 | 1,519 | 0 |
| 31 Mar 18 | 2,796 | 283 | 1,456 | 0 |
| 31 Dec 17 | 2,672 | 271 | 1,392 | 0 |
| 31 Dec 16 | 2,363 | 262 | 1,192 | 0 |
| 31 Dec 15 | 2,152 | 254 | 1,045 | 0 |
Quality Earnings: 1763 has a large one-off gain of CN¥158.4M impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: 1763's current net profit margins (5.6%) are lower than last year (6.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 1763's earnings have grown by 5.7% per year over the past 5 years.
Accelerating Growth: 1763's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 1763 had negative earnings growth (-5.3%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.2%).
Return on Equity
High ROE: 1763's Return on Equity (10.9%) is considered low.